Trial of oral metoclopramide on diurnal bruxism of brain injury

10Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Bruxism is a diurnal or nocturnal parafunctional activity that includes tooth clenching, bracing, gnashing, and grinding. The dopaminergic system seems to be the key pathophysiology of bruxism and diminution of dopaminergic transmission at the prefrontal cortex seems to induce it. We report two patients with diurnal bruxism in whom a bilateral frontal lobe injury resulted from hemorrhagic stroke or traumatic brain injury. These patients' bruxism was refractory to bromocriptine but responded to low-dose metoclopramide therapy. We propose that administering low doses of metoclopramide is possibly a sound method for treating bruxism in a brain injury patient with frontal lobe hypoperfusion on positron emission tomography imaging. © 2013 by Korean Academy of Rehabilitation Medicine.

Cite

CITATION STYLE

APA

Yi, H. S., Kim, H. S., & Seo, M. R. (2013). Trial of oral metoclopramide on diurnal bruxism of brain injury. Annals of Rehabilitation Medicine, 37(6), 871–874. https://doi.org/10.5535/arm.2013.37.6.871

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free